Skip to main content

Advertisement

Figure 2 | Stem Cell Research & Therapy

Figure 2

From: Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke

Figure 2

Acute intravenous (i.v.) administration of allogenic bone marrow-derived mesenchymal (BM-MSC) and adipose tissue-derived mesenchymal (AD-MSC) cells improved functional recovery at 24 h and 14 d after permanent middle cerebral artery occlusion (pMCAO). The scores in the Rogers (left) and rotarod tests (right) are shown. Both treatments significantly improved functional recovery with no differences in recovery between the two groups (BM-MSC or AD-MSC). Data are expressed as mean ± SD (n = 10); *P < 0.05.

Back to article page